Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane A Mitchell

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Journal of Hematology & Oncology|July 18, 2019
Emerging trends in immunotherapy for pediatric sarcomasKyle A Dyson, Brian D Stover, Adam Grippin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 26, 2008
Proteomic and immunologic analyses of brain tumor exosomesMichael W Graner, Oscar Alzate, Angelika M Dechkovskaia, et al.
Microbiology and Immunology|February 12, 2022
Effects of immune checkpoint blockade on antigen-specific CD8<sup>+</sup> T cells for use in adoptive cellular therapyElizabeth Ogando-Rivas, Paul Castillo, Noah Jones, et al.
Brain Pathology (Zurich, Switzerland)|September 12, 2009
EGFRvIII-targeted vaccination therapy of malignant gliomaBryan D Choi, Gary E Archer, Duane A Mitchell, et al.
Neuro-Oncology Advances|February 5, 2021
Adult precision medicine: learning from the past to enhance the futureAshley Ghiaseddin, Lan B Hoang Minh, Michalina Janiszewska, et al.
Nature Communications|October 19, 2018
Lin<sup>-</sup>CCR2<sup>+</sup> hematopoietic stem and progenitor cells overcome resistance to PD-1 blockadeCatherine T Flores, Tyler J Wildes, Jeffrey A Drake, et al.
Journal of Neuro-Oncology|September 4, 2003
The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumorsPeter E Fecci, Duane A Mitchell, Gary E Archer, et al.
Neuro-Oncology|January 23, 2019
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibitionAida Karachi, Changlin Yang, Farhad Dastmalchi, et al.
Frontiers in Immunology|January 23, 2023
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2<sup>+</sup>/CX3CR1<sup>+</sup> M-MDSCs into the tumor microenvironment in a redundant mannerGregory P Takacs, Christian J Kreiger, Defang Luo, et al.
Journal of Neuro-Oncology|August 7, 2020
Nanoparticles as immunomodulators and translational agents in brain tumorsAdam J Grippin, Kyle A Dyson, Sadeem Qdaisat, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Journal of Hematology & Oncology|July 18, 2019
Emerging trends in immunotherapy for pediatric sarcomasKyle A Dyson, Brian D Stover, Adam Grippin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 26, 2008
Proteomic and immunologic analyses of brain tumor exosomesMichael W Graner, Oscar Alzate, Angelika M Dechkovskaia, et al.
Microbiology and Immunology|February 12, 2022
Effects of immune checkpoint blockade on antigen-specific CD8<sup>+</sup> T cells for use in adoptive cellular therapyElizabeth Ogando-Rivas, Paul Castillo, Noah Jones, et al.
Brain Pathology (Zurich, Switzerland)|September 12, 2009
EGFRvIII-targeted vaccination therapy of malignant gliomaBryan D Choi, Gary E Archer, Duane A Mitchell, et al.
Neuro-Oncology Advances|February 5, 2021
Adult precision medicine: learning from the past to enhance the futureAshley Ghiaseddin, Lan B Hoang Minh, Michalina Janiszewska, et al.
Nature Communications|October 19, 2018
Lin<sup>-</sup>CCR2<sup>+</sup> hematopoietic stem and progenitor cells overcome resistance to PD-1 blockadeCatherine T Flores, Tyler J Wildes, Jeffrey A Drake, et al.
Journal of Neuro-Oncology|September 4, 2003
The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumorsPeter E Fecci, Duane A Mitchell, Gary E Archer, et al.
Neuro-Oncology|January 23, 2019
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibitionAida Karachi, Changlin Yang, Farhad Dastmalchi, et al.
Frontiers in Immunology|January 23, 2023
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2<sup>+</sup>/CX3CR1<sup>+</sup> M-MDSCs into the tumor microenvironment in a redundant mannerGregory P Takacs, Christian J Kreiger, Defang Luo, et al.
Journal of Neuro-Oncology|August 7, 2020
Nanoparticles as immunomodulators and translational agents in brain tumorsAdam J Grippin, Kyle A Dyson, Sadeem Qdaisat, et al.
Pageof 13